GE Healthcare Technologies Inc
NASDAQ:GEHC
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
67.39
93.87
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GEHC stock under the Base Case scenario is 89.13 USD. Compared to the current market price of 82.44 USD, GE Healthcare Technologies Inc is Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
GE Healthcare Technologies Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GEHC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
GE Healthcare Technologies Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
GE Healthcare Technologies Inc. is a leading global player in the medical technology and life sciences industry, heavily embedded within the complex fabric of healthcare solutions. With a legacy spanning over a century, the company specializes in providing advanced imaging, monitoring, biomanufacturing, and digital solutions to healthcare providers across the globe. By leveraging cutting-edge technologies such as artificial intelligence and cloud computing, GE Healthcare aims to enhance patient care while driving operational efficiency for hospitals and clinics. In a world where health outcomes heavily depend on the accuracy and efficiency of medical devices, GE Healthcare positions itself a...
GE Healthcare Technologies Inc. is a leading global player in the medical technology and life sciences industry, heavily embedded within the complex fabric of healthcare solutions. With a legacy spanning over a century, the company specializes in providing advanced imaging, monitoring, biomanufacturing, and digital solutions to healthcare providers across the globe. By leveraging cutting-edge technologies such as artificial intelligence and cloud computing, GE Healthcare aims to enhance patient care while driving operational efficiency for hospitals and clinics. In a world where health outcomes heavily depend on the accuracy and efficiency of medical devices, GE Healthcare positions itself as a trusted partner, committed to improving lives through groundbreaking innovations.
Investors should take note of GE Healthcare’s robust growth potential, particularly as it operates within the rapidly expanding healthcare sector, projected to exceed several trillion dollars in the coming years. The company's strong pipeline of products and services not only meets the immediate needs of medical professionals but also anticipates future healthcare trends, such as telehealth and precision medicine. With a solid commitment to research and development and strategic partnerships that enhance its market position, GE Healthcare is well-poised to capitalize on the ongoing demand for better healthcare solutions. As the company navigates the evolving healthcare landscape, its emphasis on sustainability and value-based care ensures that it remains at the forefront of innovation, making it an attractive prospect for investors seeking long-term growth in a changing world.
GE Healthcare Technologies Inc. operates primarily within the healthcare sector, providing a wide range of products and services that improve patient care and enhance operational efficiency for healthcare providers. Its core business segments include:
-
Imaging: This segment focuses on advanced imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and molecular imaging. These technologies are essential for diagnosis and treatment planning in various medical fields.
-
Ultrasound: GE Healthcare is renowned for its ultrasound equipment, which is utilized in obstetrics, cardiology, and various other medical specialties. This segment emphasizes real-time imaging and visualization for diagnostics.
-
Monitoring and Analytics: This segment provides patient monitoring systems, anesthesia delivery systems, and software solutions that utilize data analytics to track patient health and improve clinical outcomes. The focus is on enhancing patient safety and operational efficiency in hospitals.
-
Life Sciences: GE Healthcare Technologies has a significant presence in the life sciences field, providing bioprocessing technologies for the pharmaceutical and biotechnology industries. This segment includes equipment and services for drug development, manufacturing, and cellular therapies.
-
Digital Solutions: This segment includes software and digital tools that support healthcare providers in managing patient data, imaging workflows, and operational processes. It leverages artificial intelligence (AI) and machine learning to enhance clinical decision-making and improve patient care.
-
Healthcare Services: GE Healthcare also offers maintenance, training, and support services for healthcare providers. This segment is critical for ensuring that medical equipment remains functional and up-to-date, thereby enhancing service delivery.
-
Point-of-Care Testing: This includes portable diagnostic devices that allow healthcare providers to perform tests at or near the site of patient care, improving the speed and quality of diagnostics.
Together, these segments position GE Healthcare Technologies Inc. as a key player in the healthcare ecosystem, focusing on innovation and technology to improve patient outcomes and operational efficiency.
GE Healthcare Technologies Inc has several unique competitive advantages over its rivals in the healthcare technology sector:
-
Strong Brand Heritage: GE has been a leader in the healthcare industry for over a century. Its long-standing reputation and strong brand recognition establish trust with healthcare providers globally.
-
Extensive Product Portfolio: GE Healthcare offers a vast range of medical technologies and services, including imaging, monitoring, and diagnostics. This diverse product lineup allows them to provide comprehensive solutions that can meet the varying needs of healthcare facilities.
-
Innovative Technology: GE Healthcare emphasizes research and development, investing significantly in healthcare technology innovation. They have been at the forefront of advancements in medical imaging, such as MRI and ultrasound technologies, which gives them an edge in terms of product performance and capabilities.
-
Integration of AI and Data Analytics: GE Healthcare is integrating artificial intelligence (AI) and data analytics into its products, improving diagnostic accuracy and operational efficiency. This focus on digital healthcare solutions positions them to capitalize on growing trends in predictive analytics and personalized medicine.
-
Global Presence and Scale: With operations in over 140 countries, GE Healthcare benefits from economies of scale, enabling cost efficiencies in manufacturing and distribution. This geographic reach allows them to tap into emerging markets and diversify revenue streams.
-
Strong Customer Relationships: GE Healthcare has built longstanding relationships with healthcare providers, allowing for better customer insights and tailored product offerings. Their deep engagement with clients fosters loyalty and repeat business.
-
Regulatory and Compliance Expertise: Operating in a heavily regulated industry, GE Healthcare has extensive experience navigating compliance and regulatory challenges, enabling faster product development and market entry compared to less experienced competitors.
-
Robust After-Sales Support: The company’s emphasis on customer service and support ensures that healthcare facilities receive ongoing assistance and maintenance, enhancing customer satisfaction and retention.
-
Partnerships and Collaborations: GE Healthcare actively engages in partnerships with tech companies, research institutions, and healthcare providers to foster innovation and enhance product offerings, helping them stay ahead of trends and competitor developments.
-
Sustainability Initiatives: GE Healthcare is increasingly focusing on sustainability and environmentally friendly solutions, appealing to customers who prioritize sustainable practices in healthcare.
These advantages enable GE Healthcare Technologies Inc to maintain a competitive edge in the dynamic healthcare technology landscape.
GE Healthcare Technologies Inc faces several risks and challenges in the near future that could impact its operations, market position, and financial performance. Here are some key areas to consider:
-
Regulatory Compliance: The healthcare industry is heavily regulated, and GE Healthcare must comply with various medical device regulations, data privacy laws, and healthcare standards. Changes in regulations, such as those related to FDA approvals or data handling (e.g., HIPAA in the U.S.), could introduce compliance challenges and delays in product launches.
-
Technological Advancements: Rapid advancements in medical technology require constant innovation and investment. GE Healthcare faces the challenge of keeping up with emerging technologies, such as artificial intelligence, telemedicine, and personalized medicine, to maintain competitiveness.
-
Competition: The healthcare technology market is highly competitive, with numerous players including Siemens Healthineers, Philips, and emerging tech companies. Increased competition could lead to pricing pressures and the need for continuous innovation to differentiate products.
-
Supply Chain Disruptions: Global supply chain challenges, exacerbated by the COVID-19 pandemic, could affect the availability and cost of critical components needed for GE Healthcare’s products. This could lead to delays in production and potential loss of market share.
-
Market Demand Fluctuations: Economic factors, including changes in healthcare budgets, insurance reimbursements, and overall demand for medical imaging and diagnostics, can impact sales. Economic downturns or shifts in healthcare spending priorities could pose risks to revenue growth.
-
Intellectual Property Issues: Protecting intellectual property is crucial in technology-driven sectors. GE Healthcare may face risks related to patent infringements or litigation, which could potentially impact its ability to innovate or lead to increased legal costs.
-
Cybersecurity Threats: With increasing connectivity of medical devices and reliance on digital health solutions, GE Healthcare must address cybersecurity risks effectively. Data breaches or compromised devices could harm its reputation and lead to legal liabilities.
-
Talent Acquisition and Retention: The healthcare technology sector requires skilled professionals, and competition for talent is fierce. Attracting and retaining qualified personnel in areas like engineering and data science is a challenge that could impact operational effectiveness.
-
Global Health Crises: Future pandemics or health crises could lead to disruptions in operations, shifts in demand for specific products, and challenges in global distribution. The company's flexibility in adapting to quickly changing health landscapes will be crucial.
-
Environmental Sustainability: As corporate responsibility and sustainability become increasingly important, GE Healthcare must address environmental concerns related to its manufacturing processes and product lifecycle. Failing to meet sustainability expectations could hurt its brand image and market position.
Navigating these risks requires strategic foresight, investment in innovation, and agile operations to remain competitive in the evolving healthcare technology landscape.
Revenue & Expenses Breakdown
GE Healthcare Technologies Inc
Balance Sheet Decomposition
GE Healthcare Technologies Inc
Current Assets | 10.6B |
Cash & Short-Term Investments | 3.6B |
Receivables | 4.5B |
Other Current Assets | 2.6B |
Non-Current Assets | 23.2B |
PP&E | 2.5B |
Intangibles | 14.3B |
Other Non-Current Assets | 6.4B |
Current Liabilities | 8.7B |
Accounts Payable | 2.9B |
Accrued Liabilities | 1.5B |
Other Current Liabilities | 4.2B |
Non-Current Liabilities | 16.9B |
Long-Term Debt | 9.3B |
Other Non-Current Liabilities | 7.6B |
Earnings Waterfall
GE Healthcare Technologies Inc
Revenue
|
19.6B
USD
|
Cost of Revenue
|
-11.5B
USD
|
Gross Profit
|
8.1B
USD
|
Operating Expenses
|
-5.6B
USD
|
Operating Income
|
2.5B
USD
|
Other Expenses
|
-838m
USD
|
Net Income
|
1.7B
USD
|
Free Cash Flow Analysis
GE Healthcare Technologies Inc
USD | |
Free Cash Flow | USD |
In Q3 2024, GE HealthCare reported a 1% organic revenue growth, achieving $4.9 billion in revenues. Excluding China, growth was 5%. The company faced challenges from a 17% decline in China but experienced a 15% year-over-year increase in adjusted EPS to $1.14. They raised their adjusted EBIT margin guidance to 15.8%-16%. Looking ahead, full-year revenue growth is expected at the lower end of 1%-2% due to ongoing difficulties in China, with anticipated fourth-quarter growth exceeding 2%. The new PET imaging agent Flyrcado is projected to drive over $500 million in annual revenue once fully deployed.
What is Earnings Call?
GEHC Profitability Score
Profitability Due Diligence
GE Healthcare Technologies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
GE Healthcare Technologies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
GEHC Solvency Score
Solvency Due Diligence
GE Healthcare Technologies Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
GE Healthcare Technologies Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GEHC Price Targets Summary
GE Healthcare Technologies Inc
According to Wall Street analysts, the average 1-year price target for GEHC is 99.47 USD with a low forecast of 74.74 USD and a high forecast of 115.5 USD.
Dividends
Current shareholder yield for GEHC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
GEHC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2022-12-15. The firm's segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, therapy support, and monitoring of multiple diseases. The Patient Care Solutions segment includes medical devices, services, consumable products and digital solutions. The Pharmaceutical Diagnostics segment includes diagnostic imaging agents used to enhance radiology and nuclear medicine procedures across care pathways. The firm's product categories include Imaging, Ultrasound, Anesthesia Delivery, Diagnostic ECG, Maternal and Infant Care, Patient Monitoring, Ventilators, Pharmaceutical Imaging Agents, Digital Solutions, Refurbished Systems and others.
Contact
IPO
Employees
Officers
The intrinsic value of one GEHC stock under the Base Case scenario is 89.13 USD.
Compared to the current market price of 82.44 USD, GE Healthcare Technologies Inc is Undervalued by 8%.